These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 9796219)

  • 21. Neoadjuvant docetaxel for operable breast cancer induces a high pathological response and breast-conservation rate.
    Amat S; Bougnoux P; Penault-Llorca F; Fétissof F; Curé H; Kwiatkowski F; Achard JL; Body G; Dauplat J; Chollet P
    Br J Cancer; 2003 May; 88(9):1339-45. PubMed ID: 12778058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Taxotere as second-line for metastatic breast cancer].
    Culine S
    Rev Med Interne; 1999 Mar; 20(3):277-80. PubMed ID: 10216887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of docetaxel (Taxotere) in neoadjuvant chemotherapy of breast cancer.
    Costa SD; von Minckwitz G; Raab G; Blohmer JU; Dresel V; Eidtmann H; Hilfrich J; Jackisch C; Merkle E; Gademann G; Kaufmann M
    Semin Oncol; 1999 Jun; 26(3 Suppl 9):24-31. PubMed ID: 10426456
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Response to dexamethasone in patients with fluid retention after docetaxel.
    Chan S; Winterbottom L; Gardner S
    Lancet; 1996 May; 347(9013):1486-7. PubMed ID: 8676655
    [No Abstract]   [Full Text] [Related]  

  • 25. Taxoid compounds in breast cancer: current status and future prospects.
    Piccart MJ
    Cancer Treat Res; 1995; 78():185-207. PubMed ID: 8595143
    [No Abstract]   [Full Text] [Related]  

  • 26. Paclitaxel (Taxol) and docetaxel (Taxotere): active chemotherapeutic agents in lung cancer.
    Francis PA; Kris MG; Rigas JR; Grant SC; Miller VA
    Lung Cancer; 1995 Apr; 12 Suppl 1():S163-72. PubMed ID: 7551925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful docetaxel rechallenge with cromoglycate after major sensitivity reactions.
    Westermann AM; ten Bokkel Huinink WW; Rodenhuis S
    Ann Oncol; 1996 Jan; 7(1):104. PubMed ID: 9081381
    [No Abstract]   [Full Text] [Related]  

  • 28. Conclusion: the place of docetaxel (Taxotere) in future therapy.
    Khayat D
    Anticancer Drugs; 1996 Aug; 7 Suppl 2():53. PubMed ID: 8862713
    [No Abstract]   [Full Text] [Related]  

  • 29. Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions.
    Goble S; Bear HD
    Surg Clin North Am; 2003 Aug; 83(4):943-71. PubMed ID: 12875604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The taxoids: paclitaxel (Taxol) and docetaxel (Taxotere).
    Pazdur R; Kudelka AP; Kavanagh JJ; Cohen PR; Raber MN
    Cancer Treat Rev; 1993 Oct; 19(4):351-86. PubMed ID: 8106152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Docetaxel is a potent cytotoxic drug in the treatment of advanced breast cancer.
    Van Vaerenbergh W; Paridaens R; Thomas J; Wildiers J; Van Oosterom A
    Acta Clin Belg; 1998 Aug; 53(4):264-9. PubMed ID: 9795447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Weekly docetaxel as neoadjuvant chemotherapy for stage II and III breast cancer: efficacy and correlation with biological markers in a phase II, multicenter study.
    Estévez LG; Cuevas JM; Antón A; Florián J; López-Vega JM; Velasco A; Lobo F; Herrero A; Fortes J
    Clin Cancer Res; 2003 Feb; 9(2):686-92. PubMed ID: 12576436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The development of docetaxel (Taxotere) in non-small cell lung cancer.
    Kris MG; Miller VA; Ng KK; Grant SC
    Semin Oncol; 1997 Aug; 24(4 Suppl 14):S14-1-S14-4. PubMed ID: 9335515
    [No Abstract]   [Full Text] [Related]  

  • 34. [Fulminant hepatocellular necrosis following administration of docetaxel].
    Tomassini E; Muhizi J; al Raheb K; Steinbach G; Bemer M; Platini C
    Presse Med; 2001 Apr; 30(13):634. PubMed ID: 11346902
    [No Abstract]   [Full Text] [Related]  

  • 35. [Docetaxel (taxotere) in non-small-cell bronchial carcinoma].
    Manegold C
    Med Klin (Munich); 1997 Sep; 92 Suppl 4():10-5. PubMed ID: 9446014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nail changes secondary to docetaxel (Taxotere).
    Correia O; Azevedo C; Pinto Ferreira E; Braga Cruz F; Polónia J
    Dermatology; 1999; 198(3):288-90. PubMed ID: 10393455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Docetaxel (Taxotere): an effective agent in the management of second-line breast cancer.
    van Oosterom AT
    Semin Oncol; 1995 Dec; 22(6 Suppl 13):22-8. PubMed ID: 8604449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The current status of docetaxel for metastatic breast cancer.
    Esteva FJ
    Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):17-26. PubMed ID: 12108894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of taxanes in the treatment of breast cancer.
    Capri G; Tarenzi E; Fulfaro F; Gianni L
    Semin Oncol; 1996 Feb; 23(1 Suppl 2):68-75. PubMed ID: 8614849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Taxoids: new weapons against cancer.
    Nicolaou KC; Guy RK; Potier P
    Sci Am; 1996 Jun; 274(6):94-8. PubMed ID: 8643952
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.